Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 2.33Close
$ 1.36 - $ 6.35 52-Week Range
Ticker Information
Ticker
CYCNCompany Name
CYCLERION THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCYCLERION THERAPEUTICS INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CYCN - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 0 | 0% | $ 2.17M |
| 3/31/2025 | $ -62K | -2.98% | $ 2.08M |
| 12/31/2024 | $ 0 | 0% | $ 2M |
| 9/30/2024 | $ -239K | -123.2% | $ 194K |
| 6/30/2024 | $ -346K | 0% | $ 0 |
| 3/31/2024 | $ -346K | 0% | $ 0 |
| 12/31/2023 | $ -358K | 0% | $ 0 |
| 9/30/2023 | $ -389K | -63.98% | $ 608K |
| 6/30/2023 | $ -393K | -64.64% | $ 608K |
| 3/31/2023 | $ -376K | -41.14% | $ 914K |
Key Performance Insights, Last 5 Years
- CYCLERION THERAPEUTICS INC's latest trailing twelve months (TTM) Int. Exp. % stands at -71.93%.
- Over the past 5 years, CYCLERION THERAPEUTICS INC's average Int. Exp. % has been -26%.
- The median Int. Exp. % for CYCLERION THERAPEUTICS INC during this period was -10.39%
- CYCLERION THERAPEUTICS INC reached its highest Int. Exp. % over the past 5 years at 0.54%.
- The lowest Int. Exp. % recorded by CYCLERION THERAPEUTICS INC in the same timeframe -123.2%
CYCLERION THERAPEUTICS INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for CYCLERION THERAPEUTICS INC is calculated as follows: Int. Exp. [ $ -2.62M ] / Revenues [ $ 3.64M ]
(=) Int. Exp. % [ -71.93% ] CYCN - Interest Expense Margin, Last 5 years
-123.2%
Minimum
Sep 30, 2024
0.54%
Maximum
Sep 30, 2021
-26%
Average
-10.39%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.62% with a standard deviation of 2.19%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.48% |
| average | 1.62% |
| median | 0.79% |
| std | 2.19% |